Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Operative approach and case volume are associated with negative resection margins for adrenocortical carcinoma

  • 2021 SAGES Oral
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Surgical resection with negative margins is the treatment of choice for adrenocortical carcinoma (ACC). This study was undertaken to determine factors associated with negative resection margins.

Methods

National Cancer Database was queried from 2010 to 2016 to identify patients with AJCC/ENSAT Stage I–III ACC who underwent adrenalectomy. Patient, tumor, facility, and operative characteristics were compared by margin status (positive—PM or negative—NM) and operative approach (open—OA, laparoscopic—LA, or robotic—RA). Multivariable logistic regression was used to identify factors associated with PM.

Results

Eight hundred and eighty-one patients were identified, of which 18.4% had PM and 81.6% had NM. Patients with advanced pathologic T stage and pathologic N1 stage were more likely to have PM (vs. NM) (T3, 49.7% vs. 24.8%, p < 0.01; T4, 26.2% vs. 10.0%, p < 0.01; N1, 6.7% vs. 3.5%, p < 0.01). Patients undergoing OA (vs. LA and RA) were more likely to have advanced clinical T stage (T4, 16.6% vs. 5.7% vs. 7.8%, p < 0.01) and larger tumors (> 6 cm, 84.6% vs. 64.1% vs. 62.3%, p < 0.01). High-volume centers (≥ 5 cases) were more likely to utilize OA. Patients undergoing LA (vs. RA) were more likely to require conversion to open (20.3% vs. 7.8%, p = 0.011). On multivariable analysis, factors associated with higher odds of PM included T3 disease (OR 7.02, 95% CI 2.66–18.55), T4 disease (OR 10.22, 95% CI 3.66–28.53), and LA (OR 1.99, 95% CI 1.28–3.09). High-volume centers were associated with lower odds of PM (OR 0.67, 95% CI 0.45–0.98). There was no significant difference in margin status between OA and RA (OR 1.44, 95% CI 0.71–2.90).

Conclusion

Centers with higher ACC case volumes have lower odds of PM and utilize OA more often. LA is associated with higher odds of PM, whereas RA is not. These factors should be considered when planning the operative approach for ACC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Habra MA (2013) Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169:891–899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30:872–878

    Article  PubMed  Google Scholar 

  3. Schulick RD, Brennan MF (1999) Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 6:719–726

    Article  CAS  PubMed  Google Scholar 

  4. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25:891–897

    Article  CAS  PubMed  Google Scholar 

  5. Tella SH, Kommalapati A, Yaturu S, Kebebew E (2018) Predictors of survival in adrenocortical carcinoma: an analysis from the National Cancer Database. J Clin Endocrinol Metab 103:3566–3573

    Article  PubMed  Google Scholar 

  6. Gonzalez RJ, Shapiro S, Sarlis N, Vassilopoulou-Sellin R, Perrier ND, Evans DB, Lee JE (2005) Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. J Surgery 138:1078–1085

    Google Scholar 

  7. Leboulleux S, Deandreis D, Al Ghuzlan A, Aupérin A, Goéré D, Dromain C, Elias D, Caillou B, Travagli JP, De Baere T, Lumbroso J, Young J, Schlumberger M, Baudin E (2010) Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis? Eur J Endocrinol 162:1147–1153

    Article  CAS  PubMed  Google Scholar 

  8. Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM (2010) Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg 34:1380–1385

    Article  CAS  PubMed  Google Scholar 

  9. National Comprehensive Cancer Network Neuroendocrine and Adrenal Tumors (Version 2.2020).

  10. Gratian L, Pura J, Dinan M, Reed S, Scheri R, Roman S, Sosa JA (2014) Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. Ann Surg Oncol 21:3509–3514

    Article  PubMed  PubMed Central  Google Scholar 

  11. Park HS, Roman SA, Sosa JA (2009) Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty? Arch Surg 144:1060–1067

    Article  PubMed  Google Scholar 

  12. Margonis GA, Kim Y, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM (2016) Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes. Ann Surg Oncol 23:134–141

    Article  PubMed  Google Scholar 

  13. Brunaud L, Ayav A, Zarnegar R, Rouers A, Klein M, Boissel P, Bresler L (2008) Prospective evaluation of 100 robotic-assisted unilateral adrenalectomies. Surgery 144:995–1001

    Article  PubMed  Google Scholar 

  14. Agcaoglu O, Aliyev S, Karabulut K, Siperstein A, Berber E (2012) Robotic vs laparoscopic posterior retroperitoneal adrenalectomy. Arch Surg 147:272–275

    Article  PubMed  Google Scholar 

  15. Hupe MC, Imkamp F, Merseburger AS (2017) Minimally invasive approaches to adrenal tumors: an up-to-date summary including patient position and port placement of laparoscopic, retroperitoneoscopic, robot-assisted, and single-site adrenalectomy. Curr Opin Urol 27:56–61

    Article  PubMed  Google Scholar 

  16. Autorino R, Bove P, De Sio M, Miano R, Micali S, Cindolo L, Greco F, Nicholas J, Fiori C, Bianchi G, Kim FJ, Porpiglia F (2016) Open versus laparoscopic adrenalectomy for adrenocortical carcinoma: a meta-analysis of surgical and oncological outcomes. Ann Surg Oncol 23:1195–1202

    Article  PubMed  Google Scholar 

  17. Hu X, Yang W-X, Shao Y-X, Dou W-C, Xiong S-C, Li X (2020) Minimally invasive versus open adrenalectomy in patients with adrenocortical carcinoma: a meta-analysis. Ann Surg Oncol 27:3858–3869

    Article  PubMed  Google Scholar 

  18. Gokceimam M, Akbulut S, Erten O, Kahramangil B, Kim YS, Li P, Berber E (2021) An intra-operative video comparison of laparoscopic versus robotic transabdominal lateral adrenalectomy. Int J Med Robot Comput Assist Surg 17:e2203

    Article  Google Scholar 

  19. Gokceimam M, Kahramangil B, Akbulut S, Erten O, Berber E (2021) Robotic posterior retroperitoneal adrenalectomy: patient selection and long-term outcomes. Ann Surg Oncol 28:7497–7505

    Article  PubMed  Google Scholar 

  20. Delozier OM, Stiles ZE, Deschner BW, Drake JA, Deneve JL, Glazer ES, Tsao MW, Yakoub D, Dickson PV (2021) Implications of conversion during attempted minimally invasive adrenalectomy for adrenocortical carcinoma. Ann Surg Oncol 28:492–501

    Article  PubMed  Google Scholar 

  21. Skertich NJ, Tierney JF, Chivukula SV, Babazadeh NT, Hertl M, Poirier J, Keutgen XM (2020) Risk factors associated with positive resection margins in patients with adrenocortical carcinoma. Am J Surg 220:932–937

    Article  PubMed  Google Scholar 

  22. Dickson PV, Kim L, Yen TWF, Yang A, Grubbs EG, Patel D, Solorzano CC (2018) Adjuvant and neoadjuvant therapy, treatment for advanced disease, and genetic considerations for adrenocortical carcinoma: an update from the SSO endocrine and head and neck disease site working group. Ann Surg Oncol 25:3453–3459

    Article  PubMed  Google Scholar 

  23. DeLong JC, Chakedis JM, Hosseini A, Kelly KJ, Horgan S, Bouvet M (2015) Indocyanine green (ICG) fluorescence-guided laparoscopic adrenalectomy. J Surg Oncol 112:650–653

    Article  CAS  PubMed  Google Scholar 

  24. Lerchenberger M, Gündogar U, Al Arabi N, Gallwas JKS, Stepp H, Hallfeldt KKJ, Ladurner R (2020) Indocyanine green fluorescence imaging during partial adrenalectomy. Surg Endosc 34:2050–2055

    Article  PubMed  Google Scholar 

  25. Arora E, Bhandarwar A, Wagh A, Gandhi S, Patel C, Gupta S, Talwar G, Agarwal J, Rathore J, Chatnalkar S (2018) Role of indo-cyanine green (ICG) fluorescence in laparoscopic adrenalectomy: a retrospective review of 55 Cases. Surg Endosc 32:4649–4657

    Article  PubMed  Google Scholar 

  26. Sebastian M, Rudnicki J (2020) Recommendation for laparoscopic ultrasound guided laparoscopic left lateral transabdominal adrenalectomy. Gland Surg 9:689–694

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monica Jain.

Ethics declarations

Disclosures

Drs. Tseng, Diperi, Gonsalves, Chen, Ben-Shlomo, Shouhed, Phillips, Burch, and Jain have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tseng, J., Diperi, T., Gonsalves, N. et al. Operative approach and case volume are associated with negative resection margins for adrenocortical carcinoma. Surg Endosc 36, 9288–9296 (2022). https://doi.org/10.1007/s00464-022-09167-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-022-09167-0

Keywords